BayMed Venture Partners

BayMed Venture Partners is a venture capital investment firm based in San Francisco, California, founded in 2020. The firm specializes in investing in early-stage companies within the medical device and digital health sectors, focusing primarily on opportunities in North America and Israel. BayMed Venture Partners aims to support innovative solutions that can enhance healthcare delivery and improve patient outcomes.

Gary Gershony

Founding General Partner

Neil Meyer

Founding General Partner

2 past transactions

AtaCor Medical

Series C in 2024
Founded in 2014, AtaCor Medical specializes in developing innovative cardiac pacing solutions. Its flagship product is the AtaCor EV Temporary Pacing System, which uses an extravascular approach to restore normal heart rhythm temporarily.

Deep Blue Medical Advances

Series A in 2022
Deep Blue Medical Advances is a medical device company focused on surgical solutions for soft tissue repair and hernia treatment. It develops and manufactures hernia mesh products, including the T-Line mesh and related anchor clips, designed to improve fixation strength and reduce mesh-related failure during implantation. Founded in 2015 and headquartered in Durham, North Carolina, with an additional office in San Francisco, California, the company aims to address high hernia occurrence and recurrence by offering surgeon-invented designs such as mesh with integral suture-like extensions and faster, stronger fixation. Through its innovative mesh and fixation devices, Deep Blue Medical Advances seeks to enhance surgical outcomes, expand options in hernia care, and contribute to improvements in patient experience and recovery in the global hernia device market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.